Michael Burgess actually said...

This committee has a history of working in a bipartisan manner to improve generic and biosimilar competition.

I am uncomfortable with the idea of government action restricting patients' access to lifesaving medications.

Every one of us has heard passionate personal stories from our constituents about the ever-increasing costs of prescription drugs.

Regrettably, we are holding a quickly assembled partisan hearing on this topic today.